Stocks
Funds
Screener
Sectors
Watchlists

Latest BVF INC/IL Stock Portfolio

BVF INC/IL Performance:
2024 Q3: 9.03%YTD: 7.1%2023: 6.53%

Performance for 2024 Q3 is 9.03%, and YTD is 7.1%, and 2023 is 6.53%.

About BVF INC/IL and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, BVF INC/IL reported an equity portfolio of $3.4 Billions as of 30 Sep, 2024.

The top stock holdings of BVF INC/IL are MLTX, KYMR, RVMD. The fund has invested 32.1% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 7.2% of portfolio in KYMERA THERAPEUTICS INC.

The fund managers got completely rid off MERUS N V (MRUS), CALLIDITAS THERAPEUTICS AB (CALT) and ROIVANT SCIENCES LTD (ROIV) stocks. They significantly reduced their stock positions in CG ONCOLOGY INC, IONIS PHARMACEUTICALS INC (IONS) and PROTAGONIST THERAPEUTICS INC (PTGX). BVF INC/IL opened new stock positions in XENCOR INC (XNCR), AVALO THERAPEUTICS INC (AVTX) and TENAX THERAPEUTICS INC (TENX). The fund showed a lot of confidence in some stocks as they added substantially to CIDARA THERAPEUTICS INC (CDTX), 4D MOLECULAR THERAPEUTICS IN (FDMT) and ELEVATION ONCOLOGY INC (ELEV).

BVF INC/IL Annual Return Estimates Vs S&P 500

Our best estimate is that BVF INC/IL made a return of 9.03% in the last quarter. In trailing 12 months, it's portfolio return was 18.27%.

New Buys

Ticker$ Bought
xencor inc17,093,500
avalo therapeutics inc9,147,820
tenax therapeutics inc1,174,840
nls pharmaceutics ltd728,437
forte biosciences inc667,979

New stocks bought by BVF INC/IL

Additions to existing portfolio by BVF INC/IL

Reductions

Ticker% Reduced
cg oncology inc-58.87
ionis pharmaceuticals inc-54.43
protagonist therapeutics inc-44.26
revolution medicines inc-41.84
mirum pharmaceuticals inc-29.61
zymeworks inc-21.5
kura oncology inc-17.4
89bio inc-10.00

BVF INC/IL reduced stake in above stock

Sold off

Ticker$ Sold
nls pharmaceutics ltd-1,246,550
viracta therapeutics inc-1,965,290
roivant sciences ltd-28,987,300
unicycive therapeutics inc-1,102,420
merus n v-75,681,300
aslan pharmaceuticals ltd-315,000
calliditas therapeutics ab-29,242,500
janux therapeutics inc-18,495,600

BVF INC/IL got rid off the above stocks

Sector Distribution

BVF INC/IL has about 88.1% of it's holdings in Healthcare sector.

Sector%
Healthcare88.1
Others11.9

Market Cap. Distribution

BVF INC/IL has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP53.6
SMALL-CAP23.9
UNALLOCATED12.7
MICRO-CAP9.2

Stocks belong to which Index?

About 50.1% of the stocks held by BVF INC/IL either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200050.1
Others49.9
Top 5 Winners (%)%
FBRX
forte biosciences inc
880.7 %
PIRS
pieris pharmaceuticals inc
69.4 %
FHTX
foghorn therapeutics inc
61.9 %
KYMR
kymera therapeutics inc
58.6 %
OVID
ovid therapeutics inc
53.4 %
Top 5 Winners ($)$
MLTX
moonlake immunotherapeutics
140.3 M
KYMR
kymera therapeutics inc
90.2 M
RVMD
revolution medicines inc
35.8 M
TYRA
tyra biosciences inc
35.1 M
PTGX
protagonist therapeutics inc
29.0 M
Top 5 Losers (%)%
ELEV
elevation oncology inc
-73.7 %
FDMT
4d molecular therapeutics in
-40.6 %
GLYC
glycomimetics inc
-40.0 %
ALLK
allakos inc
-34.7 %
VIGL
vigil neuroscience inc
-15.0 %
Top 5 Losers ($)$
FDMT
4d molecular therapeutics in
-54.5 M
IONS
ionis pharmaceuticals inc
-12.4 M
ALLK
allakos inc
-5.7 M
IDYA
ideaya biosciences inc
-5.5 M
CELC
celcuity inc
-5.1 M

BVF INC/IL Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BVF INC/IL

BVF INC/IL has 55 stocks in it's portfolio. About 65% of the portfolio is in top 10 stocks. FDMT proved to be the most loss making stock for the portfolio. MLTX was the most profitable stock for BVF INC/IL last quarter.

Last Reported on: 14 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions